These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 12022323

  • 1. Preliminary definition of disease flare in juvenile rheumatoid arthritis.
    Brunner HI, Lovell DJ, Finck BK, Giannini EH.
    J Rheumatol; 2002 May; 29(5):1058-64. PubMed ID: 12022323
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
    Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2006 Jun; 54(6):1987-94. PubMed ID: 16732547
    [Abstract] [Full Text] [Related]

  • 3. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
    Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK.
    N Engl J Med; 2000 Mar 16; 342(11):763-9. PubMed ID: 10717011
    [Abstract] [Full Text] [Related]

  • 4. Etanercept therapy in children with juvenile rheumatoid arthritis.
    Hung JJ, Huang JL.
    J Microbiol Immunol Infect; 2005 Dec 16; 38(6):444-6. PubMed ID: 16341346
    [Abstract] [Full Text] [Related]

  • 5. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
    Liang TC, Yang YH, Lin YT, Chiang BL.
    J Microbiol Immunol Infect; 2005 Dec 16; 38(6):447-50. PubMed ID: 16341347
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.
    Arthritis Rheum; 2003 Apr 16; 48(4):1093-101. PubMed ID: 12687553
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
    Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2003 Jan 16; 48(1):218-26. PubMed ID: 12528122
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estimates of the discriminant ability of definitions of improvement for juvenile rheumatoid arthritis.
    Moroldo MB, Giannini EH.
    J Rheumatol; 1998 May 16; 25(5):986-9. PubMed ID: 9598903
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW.
    Ann Rheum Dis; 2009 May 16; 68(5):635-41. PubMed ID: 18413443
    [Abstract] [Full Text] [Related]

  • 12. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis.
    Henrickson M, Reiff A.
    J Rheumatol; 2004 Oct 16; 31(10):2055-61. PubMed ID: 15468375
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
    Horneff G, Ebert A, Fitter S, Minden K, Foeldvari I, Kümmerle-Deschner J, Thon A, Girschick HJ, Weller F, Huppertz HI.
    Rheumatology (Oxford); 2009 Aug 16; 48(8):916-9. PubMed ID: 19483091
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A, Pontikaki I, Teruzzi B, Desiati F, Gerloni V, Gattinara M, Cimaz R, Fantini F.
    Arthritis Rheum; 2006 May 16; 54(5):1602-7. PubMed ID: 16646003
    [Abstract] [Full Text] [Related]

  • 16. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, Cohen S, Felson D.
    Arthritis Rheum; 2003 Mar 16; 48(3):625-30. PubMed ID: 12632413
    [Abstract] [Full Text] [Related]

  • 17. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS.
    J Rheumatol; 2005 Oct 16; 32(10):2016-24. PubMed ID: 16206362
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S, Imanaka H, Maeno N, Shigemori M, Masuda K, Hokonohara M, Miyata K.
    J Rheumatol; 1996 Nov 16; 23(11):1956-62. PubMed ID: 8923375
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of etanercept in the treatment of juvenile idiopathic arthritis].
    de Inocencio Arocena J, Merino Muñoz R, Alvarez Madrid C, García-Consuegra Molina J.
    An Pediatr (Barc); 2009 Apr 16; 70(4):354-61. PubMed ID: 19324597
    [Abstract] [Full Text] [Related]

  • 20. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
    Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J.
    Arthritis Rheum; 2004 Apr 16; 50(4):1286-95. PubMed ID: 15077313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.